Crescent Acquisition Corp. (CRSA) filed an 8-K on Wednesday morning announcing they entered into a Definitive Agreement with F45 Training Holdings Inc. The fitness studio was founded in Australia in 2013, and has since expanded to 1,240 studios across 53 countries. The transaction values F45 at $845M in enterprise value or 11.9x 2021 EBITDA. Details below.
- $75M cash to F45 balance sheet, $20M of that to pay down revolver
- $50M FPA from sponsor
- $204M of Crescent’s $304 cash (no redemptions) going to co-founder payout (no longer with company)
- EBITDA forecast assumes return to normal growth rate
- Grew 48% in 2019, 2021 estimates put the two-year CAGR at 51%
- F45 says many markets already seeing weekly visits eclipse 2019 levels
- Attractive franchisee economics driving growth projections
- Less sq. ft. than traditional gyms, less start-up costs, and higher ROI for franchisees
- Average franchise takes 6 months and 75 members to break even
- Balanced revenue segments between Franchise and Equipment & Merchandise
- Franchise revenue is higher margin segment
- Management will be entitled to earn-out payments of 5M Class-B shares and 5M Class-C shares
- Contingent upon share performance of the combined company over a five-year period, convertible to Class-A common stock
- Transaction expected to close by end of third quarter
Quick Takes: The transaction is a bet on a return to “normal” given it assumes a continued rebound in fitness studio utilization and pre-covid new franchise opening rates. However, most of the presentation is based on pre-Covid figures. To complicate matters, we don’t really know when the world will return to normal, but there is also this looming cloud of second-wave Covid infections or even continued first waves. And while F45 has pivoted to live-streaming classes as a response to the pandemic, revenue figures have not been provided or at what prices they are charging for online versus in-studio (or if there’s no difference). Additionally, $204 million is being paid to a seller who is no longer with the company, which is a lot of cash. Nevertheless, the F45 model is unique in that its efficient studio design allows the platform to leverage technology to provide a scale-able franchise model. The company also promises to never repeat a fitness class routine and has every gym host the same routine together. The idea there is you can maintain a consistent experience between gyms and not worry about having to repeat a class you already took at a different gym. However, there are still a lot of question marks around this transaction. This is day-one of their announcement, so perhaps more information will be forthcoming.
- The transaction comes at 11.9x 2021 EBITDA, or 12.6x pre-Covid 2020 EBITDA estimates
- 2021 valuation is 30-50% below peers, but most of the peers aren’t growing nearly as fast
- The transaction on a pre-Covid EBITDA figure is more in-line with the comp set
- F45 is valued at $681k per box
- For comparison, Planet Fitness is valued at over $2.8M per box
- Anticipated leverage will be reduced to zero on a net debt basis
- From 0.5x pre-transaction based on 2021 EBITDA
- Credit Suisse is serving as financial and capital markets advisor.
- BofA Securities is serving as capital markets advisor.
- Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal advisor to Crescent.
- Goldman Sachs & Co. LLC and J.P. Morgan are serving as financial advisors.
- Gibson Dunn & Crutcher LLP is serving as legal advisor to F45.
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: Circle spokesperson denies blaming SEC for failed deal, BuzzFeed CEO says AI-powered content will be part of core business, and FaZe Clan faces possible delisting Circle Spokesperson Denies Blaming SEC for Failed $9 Billion Deal...
Health Sciences 2 (NASDAQ:HSAQ) announced that it closed its combination with Orchestra BioMed on January 26. HSAQ ahead of its vote pre-announced redemption figures of 1,597,888 shares equating to 67.7% redemptions, however, that’s still subject to change. However, today it was noted that Orchestra BioMed is to receive $70 million in gross proceeds including $20...
Carbon capture technology has long been talked about, and it is finally in operation with LanzaTech among the pioneers. Its plants are turning potential emissions into clothing, household goods and sustainable fuels. SPAC cash is now also an accelerant in this new process as the company announced a $1.7 billion combination with AMCI II last March. This week, we caught up with...
In this series we’ll be examining successful SPAC deals from the past both in the terms and circumstances of their de-SPAC processes and how they have weathered the storms that have followed after their public listings with research from SPACInsider contributor Anthony Sozzi. Thirty months does not sound like that long, but it’s been a...
Seaport Calibre Materials Acquisition Corp. (Nasdaq: SCMA) announced this afternoon that it is pushing today’s special meeting back until January 31. The SPAC is currently facing a completion deadline of February 1, but is looking to extend its timeline by an additional six months to August 1. Stockholders may elect to redeem their shares for a pro rata...